Edition:
United States

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

0.65USD
20 Apr 2018
Change (% chg)

$0.01 (+1.23%)
Prev Close
$0.64
Open
$0.65
Day's High
$0.65
Day's Low
$0.65
Volume
360
Avg. Vol
43,024
52-wk High
$6.44
52-wk Low
$0.63

Select another date:

Mon, Apr 2 2018

BRIEF-Reshape Lifesciences Reports Qtrly Loss Per Share Of $0.45‍​

* RESHAPE LIFESCIENCES ANNOUNCES FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS

BRIEF-Reshape Lifesciences Announces $6 Million Registered Direct Offering

* RESHAPE LIFESCIENCES ANNOUNCES $6 MILLION REGISTERED DIRECT OFFERING Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Reshape Lifesciences Reschedules Fourth Quarter And Full Year 2017 Conference Call To April 2, 2018

* RESHAPE LIFESCIENCES ANNOUNCES UPDATE ON INTEGRATION EFFORTS AND RESCHEDULES FOURTH QUARTER AND FULL YEAR 2017 CONFERENCE CALL TO APRIL 2, 2018

BRIEF-ReShape Lifesciences Agrees With Academy Medical To Provide Reshape Balloon To Department Of Defense Facilities

* RESHAPE LIFESCIENCES ANNOUNCES AGREEMENT WITH ACADEMY MEDICAL TO PROVIDE RESHAPE BALLOON AND RESHAPE VBLOC TO DEPARTMENT OF DEFENSE FACILITIES

BRIEF-ReShape Lifesciences Q4 Preliminary Revenue About $795,000

* RESHAPE LIFESCIENCES REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 REVENUE

BRIEF-Endeavour Medtech Growth Reports 10.8 Pct Passive Stake In Reshape Lifesciences Inc

* ENDEAVOUR MEDTECH GROWTH LP REPORTS 10.8 PERCENT PASSIVE STAKE IN RESHAPE LIFESCIENCES INC AS OF DECEMBER 19, 2017 - SEC FILING‍​ Source text for Eikon: (http://bit.ly/2D8uKeR) Further company coverage:

BRIEF-SVLSF IV Reports 14 Pct Passive Stake In Reshape Lifesciences

* SVLSF IV, LLC REPORTS 14 PERCENT PASSIVE STAKE IN RESHAPE LIFESCIENCES AS OF DEC 19 - SEC FILING Source text : (http://bit.ly/2lp7hu7) Further company coverage:

BRIEF-Reshape Lifesciences Inc - ‍Received Order For Reshape Integrated Dual Balloon System From Al Zahrawi ​

* RESHAPE LIFESCIENCES INC - ‍RECEIVED ORDER FOR RESHAPE INTEGRATED DUAL BALLOON SYSTEM FROM AL ZAHRAWI MEDICAL​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

BRIEF-Reshape Lifesciences qtrly loss per share $1.06‍​

* Reshape Lifesciences announces third quarter 2017 financial results

BRIEF-Enteromedics Inc says ‍has formally changed its name to Reshape Lifesciences Inc​

* Enteromedics Inc - ‍has formally changed its name to Reshape Lifesciences Inc​ Source text for Eikon: Further company coverage:

Select another date: